New registry aims to unlock secrets of rare diseases
NCT ID NCT06573723
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study is creating a large database to collect information on people with rare diseases like amyloidosis, sarcoidosis, and Gaucher disease. Researchers will track patients' health over time, including their symptoms, treatments, and outcomes. The goal is to improve diagnosis and care for these often-misunderstood conditions.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help doctors spot rare diseases earlier and better understand how they progress and respond to treatments.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test new therapies. Results depend on data quality and may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Italiano de Buenos Aires
RECRUITINGBuenos Aires, Buenos Aires, C1199ABB, Argentina
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A hidden warning in your wrist? surgery may reveal heart risk
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Hidden heart risks in Wilson's disease: a new scan could spot them early
- Scoliosis's hidden toll: can we predict lung and heart risks?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?
- Could a simple mineral boost recovery after pediatric colon surgery?